Crohn’s and Colitis UK welcomes the recommendation from NICE (National Institute for Health Care Excellence) that faecal calprotectin be used to support a diagnosis of Crohn’s Disease or Ulcerative Colitis (known collectively as Inflammatory Bowel Disease), in conjunction with other appropriate processes.
The use of faecal calprotectin, which identifies inflammation in the bowel, could accelerate diagnoses in future.
We know that people with IBD can experience long delays in receiving a diagnosis, as symptoms are often confused with Irritable Bowel Syndrome.
Related Links
The use of faecal calprotectin, which identifies inflammation in the bowel, could accelerate diagnoses in future.
We are now looking forward to NICE’s work on developing the Quality Standards for IBD, which will begin in December. These Standards will be essential for mandating good quality care for anyone receiving a diagnosis of IBD.
We know that people with IBD can experience long delays in receiving a diagnosis, as symptoms are often confused with Irritable Bowel Syndrome.
Related Links
No comments:
Post a Comment